Personal information

Verified email domains

Activities

Works (5)

Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)

Expert Review of Clinical Pharmacology
2024-09 | Journal article
Contributors: Katyayini Aribindi; Gabrielle Y. Liu; Timothy E. Albertson
Source: check_circle
Crossref

Update on the pharmacological treatment of chronic obstructive pulmonary disease

Expert Opinion on Pharmacotherapy
2024-09-21 | Journal article
Contributors: Madeleine R. Jacques; Brooks T. Kuhn; Timothy E. Albertson
Source: check_circle
Crossref

Investigational pharmacological agents for the treatment of ARDS

Expert Opinion on Investigational Drugs
2024-03-03 | Journal article
Contributors: Katyayini Aribindi; Michelle Lim; Satyan Lakshminrusimha; Timothy Albertson
Source: check_circle
Crossref

A ten-year retrospective California Poison Control System experience with possible amatoxin mushroom calls

Clinical Toxicology
2023-11-02 | Journal article
Contributors: Timothy E. Albertson; Richard F. Clark; Craig G. Smollin; Rais Vohra; Justin C. Lewis; James A. Chenoweth; Jacqueline C. Stocking
Source: check_circle
Crossref

SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis

2021-02-24 | Preprint
Contributors: David A. Coil; Timothy Albertson; Shefali Banerjee; Greg Brennan; A.J. Campbell; Stuart H. Cohen; Satya Dandekar; Samuel L. Díaz-Muñoz; Jonathan A. Eisen; Tracey Goldstein et al.
Source: check_circle
Crossref

Peer review (5 reviews for 4 publications/grants)

Review activity for Drugs (1)
Review activity for Drugs & therapy perspectives (1)
Review activity for Journal of medical toxicology. (2)
Review activity for Toxicon. (1)